Optimi Health Enters Asian Market, Collaborates With PsiloThai on Psilocybin Research

MT NewswiresJul 23 11:00 ET

Optimi Health Up 7.8% as After Health Canada Go-Ahead to Supply MDMA and Psilocybin to Patients in Australia

MT NewswiresJun 25 11:30 ET

Optimi Health Up 12% After Reporting Drug Establishment License From Health Canada

MT NewswiresJun 3 14:07 ET

Optimi Health to Be Sole Supplier of Psilocybin for ATMA Journey Centers Phase II Trial

MT NewswiresMay 22 09:41 ET

Optimi Health Notes Lykos Therapeutics and FDA Priority Review of New Drug Application

MT NewswiresFeb 12 08:00 ET

Optimi Health Secures Amendment to Increase Quantities of MDMA, MDA, and 2C-B

MT NewswiresJan 19 07:56 ET